Ilise Lombardo
Amministratore Delegato presso Noema Pharma AG
Profilo
Ilise Lombardo is the founder of Arvelle Therapeutics International GmbH, which was founded in 2019.
She held the title of Chief Medical Officer at Arvelle Therapeutics International GmbH.
Currently, Dr. Lombardo was the Chief Executive Officer & Director at Noema Pharma AG, starting in 2021.
Dr. Lombardo's former positions include Medicines Development Lead at Pfizer Inc., Vice President-Clinical Research at FORUM Pharmaceuticals, Inc., Assistant Professor at The Trustees of Columbia University in The City of New York, and Assistant Professor at The New York State Psychiatric Institute.
From 2015 to 2019, she was the Senior Vice President-Clinical Research at Sio Gene Therapies, Inc. She also served as the President-Therapeutics Division at Kriya Therapeutics, Inc. Dr. Lombardo's education includes an undergraduate degree from Brown University, a graduate degree from the University of Cambridge, and a doctorate degree from Yale University.
Posizioni attive di Ilise Lombardo
| Società | Posizione | Inizio |
|---|---|---|
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Amministratore Delegato | 21/06/2023 |
Precedenti posizioni note di Ilise Lombardo
| Società | Posizione | Fine |
|---|---|---|
| SIO GENE THERAPIES INC. | Direttore Tecnico/Scientifico/R&S | 01/02/2019 |
The New York State Psychiatric Institute
 The New York State Psychiatric Institute Medical/Nursing ServicesHealth Services The New York State Psychiatric Institute is an organization that is involved in academic research. The non-profit company is based in New York, NY. The company has an institutional review board that is part of a federal oversight system created to protect the rights and well-being of research participants. | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Formazione di Ilise Lombardo
| Brown University | Undergraduate Degree |
| University of Cambridge | Graduate Degree |
| Yale University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Aziende private | 6 |
|---|---|
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
The New York State Psychiatric Institute
The New York State Psychiatric Institute Medical/Nursing ServicesHealth Services The New York State Psychiatric Institute is an organization that is involved in academic research. The non-profit company is based in New York, NY. The company has an institutional review board that is part of a federal oversight system created to protect the rights and well-being of research participants. | Health Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Health Technology |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Commercial Services |
Noema Pharma AG
Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Ilise Lombardo
